1. Alberts DS, Mason-Liddil N (1989) Carboplatin in the treatment of ovarian cancer. Semin Oncol 16 [Suppl 5]:19–26
2. Alberts D, Green S, Hannigan E et al. (1989) Improved efficacy of carboplatin (carbo P)/cyclophosphamide (CPA) vs cisplatin (cisP)/CPA: preliminary report of a phase III randomized trial in stages III–IV, suboptimal ovarian cancer (OV CA). Proc Am Soc Clin Oncol 8:151 [C-588]
3. Allen LM, Creaven PJ (1972) Effect of microsomal activation on interaction between ifosfamide and DNA. J Pharm Sci 61:2009–2011
4. Antman KH, Ryan L, Elias A, Sherman D, Grier HE (1989) Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma. J Clin Oncol 7:126–131
5. Araujo C, Cervellino J, Tessler J (1982) Combined modality therapy with DTIC (D), cyclophosphamide (C), methotrexate (M) vs. D, ifosfamide and M in non-squamous cell lung cancer (abstract). In: Proc. 13th International Cancer Congress, Seattle, p 351